Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (41)

2024

  1. Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 243-253

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

    Science (New York, N.Y.), Vol. 379, Núm. 6632, pp. eabo3627

2022

  1. Mortality in Persons with Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis

    JAMA Pediatrics, Vol. 176, Núm. 4, pp. E216401

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Exome-wide rare variant analysis in familial essential tremor

    Parkinsonism and Related Disorders, Vol. 82, pp. 109-116

  2. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Journal of Experimental Medicine, Vol. 218, Núm. 6

2020

  1. Active commuting, physical activity, and sedentary behaviors in children and adolescents from spain: Findings from the ANIBES study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 2

  2. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  3. Inclusion of resistance routines in a hypoxia training program does not interfere with prevention of acute mountain sickness

    Physician and Sportsmedicine, pp. 1-7

  4. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

2019

  1. Effect of iron supplementation on the modulation of iron metabolism, muscle damage biomarkers and cortisol in professional cyclists

    Nutrients, Vol. 11, Núm. 3

  2. Impact of magnesium supplementation in muscle damage of professional cyclists competing in a stage race

    Nutrients, Vol. 11, Núm. 8

  3. Prediction models for voriconazole pharmacokinetics based on pharmacogenetics: AN exploratory study in a Spanish population

    International Journal of Antimicrobial Agents, Vol. 54, Núm. 4, pp. 463-470

2018

  1. Dietary intake and food sources of niacin, riboflavin, thiamin and vitamin B6 in a representative sample of the spanish population. The anthropometry, intake, and energy balance in Spain (ANIBES) study

    Nutrients, Vol. 10, Núm. 7

  2. Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

    Basic and Clinical Pharmacology and Toxicology, Vol. 123, Núm. 4, pp. 474-485

  3. Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 565-577

  4. Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48)

    Neurology, Vol. 91, Núm. 21, pp. E1988-E1998

  5. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

    Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 6, pp. 596-605

  6. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis

    American Journal of Clinical Dermatology, Vol. 19, Núm. 2, pp. 209-222